Asacol Buyers Say Product-Hopping Suit Requires Trial
By Dani Kass · June 18, 2019, 5:54 PM EDT
Buyers of Allergan's ulcerative colitis drugs have told a Massachusetts federal court that they were coerced into paying for higher-priced medication when the company blocked a generic drug from the market,...
To view the full article, register now.